These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33761734)

  • 1. High expression of MMP28 indicates unfavorable prognosis in pancreatic cancer.
    Chen Z; Huang J; Li M; Zhang L; Wan D; Lin S
    Medicine (Baltimore); 2021 Mar; 100(12):e25320. PubMed ID: 33761734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreatic cancer.
    Luan H; Jian L; Huang Y; Guo Y; Zhou L
    Sci Rep; 2023 Oct; 13(1):17211. PubMed ID: 37821678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulated MMP28 in Hepatocellular Carcinoma Promotes Metastasis via Notch3 Signaling and Predicts Unfavorable Prognosis.
    Zhou J; Zheng X; Feng M; Mo Z; Shan Y; Wang Y; Jin J
    Int J Biol Sci; 2019; 15(4):812-825. PubMed ID: 30906212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer.
    Jiao Y; Fu Z; Li Y; Zhang W; Liu Y
    PLoS One; 2019; 14(1):e0211291. PubMed ID: 30695070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
    Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
    Zhang Q; Xia T; Qi C; Du J; Ye C
    BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIST3H2A is a potential biomarker for pancreatic cancer: A study based on TCGA data.
    Zhao M; Dai R
    Medicine (Baltimore); 2021 Nov; 100(46):e27598. PubMed ID: 34797282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma.
    Chen A; Ding S; Shen X; Lin X
    Comput Math Methods Med; 2021; 2021():9932088. PubMed ID: 34367321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase 28 is regulated by TRIF- and type I IFN-dependent signaling in macrophages.
    Long ME; Gong KQ; Volk JS; Eddy WE; Chang MY; Frevert CW; Altemeier WA; Gale M; Liles WC; Manicone AM
    Innate Immun; 2018 Aug; 24(6):357-365. PubMed ID: 30068264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Matrix Metalloproteinase 28 Expression is Associated with Poor Prognosis in Pancreatic Adenocarcinoma.
    Liu N; Zhong L; Ni G; Lin J; Xie L; Li T; Dan H; Chen Q
    Onco Targets Ther; 2021; 14():4391-4406. PubMed ID: 34408436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying and Validating an Acidosis-Related Signature Associated with Prognosis and Tumor Immune Infiltration Characteristics in Pancreatic Carcinoma.
    Tang P; Qu W; Wu D; Chen S; Liu M; Chen W; Ai Q; Tang H; Zhou H
    J Immunol Res; 2021; 2021():3821055. PubMed ID: 34993253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer.
    Sun L; Guo C; Cao J; Burnett J; Yang Z; Ran Y; Sun D
    Int J Med Sci; 2017; 14(7):655-661. PubMed ID: 28824297
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated expression of growth-regulated oncogene-alpha in tumor and stromal cells predicts unfavorable prognosis in pancreatic cancer.
    Lian S; Zhai X; Wang X; Zhu H; Zhang S; Wang W; Wang Z; Huang J
    Medicine (Baltimore); 2016 Jul; 95(30):e4328. PubMed ID: 27472713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer.
    Chen Y; Wang C; Song J; Xu R; Ruze R; Zhao Y
    Front Immunol; 2021; 12():758004. PubMed ID: 34887861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
    Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y
    EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of PHYH for overall survival (OS) in clear cell renal cell carcinoma (ccRCC).
    Zhengqi Q; Zezhi G; Lei J; He Q; Jinyao P; Ying A
    Eur J Med Res; 2021 Jan; 26(1):9. PubMed ID: 33468235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrate analysis of the promote function of Cell division cycle-associated protein family to pancreatic adenocarcinoma.
    Xing C; Wang Z; Zhu Y; Zhang C; Liu M; Hu X; Chen W; Du Y
    Int J Med Sci; 2021; 18(3):672-684. PubMed ID: 33437202
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical Value of lncRNA LUCAT1 Expression in Liver Cancer and its Potential Pathways.
    Jiao Y; Li Y; Ji B; Cai H; Liu Y
    J Gastrointestin Liver Dis; 2019 Dec; 28(4):439-447. PubMed ID: 31826070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.